News
-
Certara, the leading provider of in silico drug development technologies, to be bought by EQT
On Tuesday 11 July 2017 Arsenal Capital Partners announced to be in the process to sell its portfolio company Certara to the private equity firm EQT
-Read more-
-
Great achievements for the EU funded CHIC project
In a recent press release the EC officially speaks about the “great achievements” of the EU-US integrating research project on in silico oncology: CHIC
-Read more-
-
EMA- Revised guideline on first-in-human clinical trials
On 26 July, the European Medicines Agency (EMA) presented a first revision of the guideline on first-in-human clinical trials, which outlines strategies to identify and mitigate risks for trial participants.
-Read more-
-
IMI launches €130 million calls for proposals
On 19 July, the Innovative Medicines Initiative (IMI) launched two new Calls for proposals (Call 11 and Call 12) with topics regarding Alzheimer’s disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results with a total budget of over € 130 million.
-Read more-
-
EPSCO informal meeting
On 20 July an informal meeting of EPSCO (Employment, Social Policy, Health and Consumer Affairs Council configuration) in Tallinn, the EU ministers for health discussed the future of digital solutions in health.
-Read more-
-
Commission to invest €97 million to help 64 small businesses bring their innovations to the market
On 17 July the European Commission announced that 64 small and medium-sized companies (SMEs) from 16 countries were selected for funding in the Phase 2 of the Horizon 2020 SME Instrument.
-Read more-
